RxDoctor Payments DataLook up a doctor →

Allan Espinosa Morazan, MD

Medical Oncology · Prescott, AZNPI 1225350788

Payments from drug & device makers

$1,067,668in general payments, 2019–2025

Across 344 payments — averaging $3103.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aadi Bioscience, Inc.$709K
  • Mirati Therapeutics, Inc.$227K
  • Eli Lilly$68K
  • Janssen Research & Development, LLC$34K
  • AstraZeneca$14K
  • AbbVie$9K
  • plus $7K from 47 others
$5,351in research payments, 2019–2025

Across 1 payment — averaging $5351.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,067,668 in reported general payments places this provider in the 90th percentile of 59 medical oncology providers in Arizona.

See all medical oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$5,553,503
Medicare patients
1,006
Services billed
212,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Prescott

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →